The new penem antibiotic HRE664 displays potent antibacterial activity in vitro against a broad spectrum of clinically relevant bacterial strains including Gram-negative and Grampositive aerobes and anaerobes.
With an MIC 90% of 0.43 /*g/ml, it is also active against methicillin-resistant staphylococci. HRE 664 is extremely stable against /3-lactamases, it binds preferentially to the penicillin-binding proteins 2, 3, 5 and 6 of Escherichia coli.
Besides penicillins and cephalosporins there are other antibacterial compounds such as the penems, which also possess the /3-lactam-ring. In recent years there has been great interest in exploiting the modification of these compounds. Although manyhave been synthesized, only a few were submitted to broad preclinical and clinical investigations. Penemantibiotics are characterized by broad antibacterial spectra, including both aerobic and anaerobic Gram-positive and Gramnegative species1"3).
Here we report on the in vitro antibacterial activity of the new parenteral penem HRE664 (sodium 5( Fig. 1 ).
Materials and Methods

Test Strains
The bacterial strains used were clinical isolates collected between 1978 and 1983 from various hospitals in Europe together with laboratory strains maintained in our department. All bacterial strains were stored on agar slants at room temperature or in liquid nitrogen. Antibiotics HRE664 was synthesized by Hoechst UK, Milton Keynes. All other antibiotics used are commercially available.
Susceptibility Testing
The susceptibility of aerobic and anaerobic bacteria was tested using an agar dilution method with Mueller-Hinton agar and Wilkins-Chalgren agar, respectively4).
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The influence of the inoculum size on the activity of HRE664 was examined in serial dilution tests in Mueller-Hinton medium(Difco). Five simultaneously prepared geometrical dilution series of the compound were inoculated with suspensions containing different densities of the test organism. The initial counts were approximately 1 x lO2, 103, 104, 105 and 106 cfu/ml of nutrient medium.
Influence of the pH of the Culture Medium The effect of the pH on the activity of HRE664 wasdeter mined in heart infusion medium (Difco) which had been adjusted to values between pH 5.5 and pH 9. The MICs of HRE664 for the test strains were determined in this mediumby the serial dilution method.
Killing Curves Mueller-Hinton mediumwas inoculated with the individual test strains and incubated at 37°C on a rotary shaker. After 2 hours HRE664 was added to the cultures in different concentrations. Samples were withdrawn at intervals, diluted with saline and spread on agar plates. After 18 hours at 37°C the numberof cfu/ml were counted.
Induction The binding of HRE664 to PBPs of Escherichia coli K-12 was determined using [125I]ampicillin5).
Results
Activity against Aerobic and Facultative Anaerobic Bacteria HRE664 possesses a broad antibacterial spectrum (Table 1) , which includes both Staphylococci and Streptococci. The in vitro activity of HRE664 against Staphylococci was clearly superior to all compared compounds. With an MIC90% of 0.43 //g/ml, HRE664 is also active against methicillinresistant Staphylococcus aureus (MR&4). Against Enterococci HRE664 also has a significantly higher activity than the other compounds (MIC 90 % =5.04 /*g/ml).
Only against Pseudomonas aeruginosa and Pseudomonas maltophilia HRE664 shows very limited activity. However, HRE664 shows excellent activity against other strains of Pseudomonas, the MIC 90% being 0.29 jug/ml.
HRE664 is the most active compoundagainst Acinetobacter sp. The Enterobacteriaceae were highly susceptible to HRE664. Ninety % of the E. coli, Salmonella sp., Klebsiella sp. and Citrobacter strains were inhibited at 1^g/ml or less.
All strains of Enterobacter sp., Serratia sp., indole-negative and indole-positive Proteus sp. are inhibited at therapeutically relevant concentrations of 4~8 //g/ml.
Activity against Anaerobes Table 2 shows the MICs of HRE664 and three reference compounds against Gram-positive and Strain producing /3-lactamase.
Inoculum size.
Gram-negative anaerobes. HRE664 is the most active compound against nearly all strains testedeven when compared with metronidazole. The highest MICdetermined for some Bacteroides strains is 0.625 //g/rnl.
Influence of the Inoculum Size on the MIC The MICs of HRE664 determined with different sizes of inocula of various test organisms are listed in Table 3 . From these values it can be deduced that the inoculum size has little or no effect on the in vitro activity of HRE664 against /3-lactamase producing or non-producing strains. Effect of the pH of the Culture Medium on the MIC From Table 4 , it can be seen that the antibacterial activity of HRE 664 against the Gramnegative test strains and Streptococcus faecium is virtually unaffected by the pH of the test medium. The MICs determined between pH 5.5 and pH 9.0 differ only by one to two dilution steps which is in the range of variation of the assay method.
However, for the other test strains marked differences are evident in the MICs of 4 {Strep-tococcus pyogenes A 77), 6 (Staphylococcus sp. E 710) and more than 7 dilution steps (Staphylococcus aureus SG 511). HRE664 is far more active at an acidic pH than at basic pH values against these strains. Bactericidal Activity Figs. 2 and 3 show the bactericidal activity of HRE664 against E. coli TEMI and S. aureus SG 511. The slope of the curves in Fig. 2 demonstrates that the number of surviving E. coli cells decreases steadily after the addition of HRE664 in concentrations corresponding to the MICand 2-fold MIC. At 1/2 MIC, HRE 664 induced a 2-hour retardation in bacterial growth. With S. aureus SG 511 (Fig. 3) , the addition of HRE664 at one and two times the MIC, the number of cfu in the culture increased slightly for 1 hour but subsequently decreased rapidly. At sub-inhibitory concentrations (1/2 MIC), S. aureus SG 511 was not inhibited by HRE 664.
/5-Lactamase Stability Table 5 shows the relative rates of hydrolysis of HRE664 and cefotaxime. The data indicate that HRE664 is extremely stable against all /3-lactamases tested. No significant hydrolysis could be detected for HRE664 -even against chromosomally coded enzymes which hydrolyze cefotaxime rather rapidly.
Affinity for Penicillin-binding Proteins (PBPs)
As shown in Fig. 4 , HRE 664 binds preferentially to the PBP 2, 3c, 5 and 6. Binding to PBP 1 can only be seen at higher concentrations (1 /^g/ml) of HRE664. In the in vitro bactericidal assay, binding to PBP 2 causes the formation of round shaped forms which lyze rapidly at the MICor above.
Discussion
In contrast to moderncephalosporins and penicillins, the penemantibiotics have showna unique antibacterial spectrum which includes anaerobic strains as well as Gram-positive and most Gramnegative pathogens1"50. These properties can also be found with the new penem HRE664. The results presented here clearly demonstrate that HRE664 is much more potent against Gram-positive strains than the compared cephalosporins ceftazidime and cefotaxime. However, slightly higher MICs of HRE 664 have been determined for most Gram-negative pathogens, which nevertheless should allow successful therapy of infections caused by these organisms.
In contrast to other /3-lactams, HRE664 also exhibits marked activity against Gram-positive and Gram-negative anaerobic bacteria. Its activity against these strains is clearly superior to that of cefoxitin and metronidazole-agents, which are normally used in anaerobic infections.
Since initial results also show excellent chemotherapeutic activity in vivo in experimental infections, we think it would be worthwhile to continue the evaluation of HRE664.
